key: cord-0869047-n2ocycfb
authors: Mansuri, Zeeshan; Adnan, Mahwish; Motiwala, Fatima; Zafar, Muhammad Khalid; Jolly, Taranjeet; Jain, Shailesh
title: Risk of QTc prolongation with Chloroquine/Hyroxychloroquine and Azithromycin treatment for COVID‐19: Quantification and precautions for a busy clinician
date: 2020-07-03
journal: J Arrhythm
DOI: 10.1002/joa3.12393
sha: 2cccf1b9a90dbaeab70e19c2340fd3243021c66f
doc_id: 869047
cord_uid: n2ocycfb

nan

To the Editor, 3 × 150 mg tablets and one placebo tablet twice daily on day 0, 3 × 150 mg tablets plus one placebo tablet once a day, then four placebo tablets from day 1 to day 4, then four placebo tablets twice daily from day 5 to day 9; total dose 2.7 g). 18.9% in the high dose group and 11.1% of the low dose group had prolonged QTc from normal to greater than 500 ms. There were no instances of ventricular tachycardia or torsade de pointes. 5 The administration of H-CHQ in the current setting of the COVID-19 crisis is experimental. There are small trials that are already underway, but until we get more robust research, the use of H-CHQ with or without Azithromycin is likely to be widespread. In the current review, we found that the risk of QTc prolongation when using CHQ/H-CHQ alone or in combination with Azithromycin is between 10 and 40 ms for most cases in 11%-33% of the cases. 

FDA cautions use of hydroxychloroquine/chloroquine for COVID-19

Prolongamento do intervalo QT do eletrocardiograma em pacientes reumáticos usando antimaláricos

Zithromax (azithromycin tablets) and azithromycin for oral suspension

Multicenter Collaboration Group of Department of Science and Technology of Guangdong Province and Health Commission of Guangdong Province for Chloroquine in the Treatment of Novel Coronavirus Pneumonia. Expert consensus on chloroquine phosphate for the treatment of novel coronavirus pneumonia

Effect of high vs low doses of chloroquine diphosphate as adjunctive therapy for patients hospitalized with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection: a randomized clinical trial